10-K/A XBRL

AMENDMENT NO. 1 TO FORM 10-K

Company: Pasithea Therapeutics Corp.
Filed: May 12, 2022
Period of Report: December 31, 2021
Accession Number: 0001213900-22-025941

View Document ↗ View on SEC.gov ↗